by Talking Medicines | Jan 20, 2021
We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee...
by Talking Medicines | Jan 5, 2021
COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that “There has been a growing realisation that pharmaceutical companies must...
by Talking Medicines | Dec 2, 2020
DIGIT spoke with Elizabeth Fairley and Ellie Halliday of Talking Medicines about keeping your medical data safe in a Covid world. Medical data is among the most sensitive information a company can gather, store or track, and the coronavirus pandemic has heightened...
by Talking Medicines | Nov 16, 2020
Data tech innovator Talking Medicines, which uses advanced AI to provide pharmaceutical companies with real-time data intelligence, has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and...
by Talking Medicines | Nov 9, 2020
Hot off of the press on raising £1.1M Talking Medicines are building out a world class product and tech team to realise its mission of creating the world’s first social intelligence company for the pharmaceutical industry. In line with plans to scale up its AI-based...
by Talking Medicines | Nov 4, 2020
Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has received a significant boost with a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the...
